Cynthia A. Stuenkel, MD, is a Clinical Professor of Medicine at the University of California, San Diego (UCSD) School of Medicine and an attending physician for their Endocrinology and Metabolism Service. At UCSD, in 1988, she established one of the first menopause clinics in the US. She lectures nationally and internationally regarding management of postmenopausal women and hormone therapy, cardiovascular disease, osteoporosis, and breast cancer prevention. In 2012, Dr. Stuenkel helped develop and then served as the National Spokesperson for the Endocrine Society’s Hormone Health Network Menopause Map. She chaired The Endocrine Society’s 2015 Clinical Practice Guidelines on Treatment of Symptoms of the Menopause and spoke on behalf of The Endocrine Society at the November 2015 FDA workshop to review labeling for low dose vaginal estrogen therapies. She previously coauthored menopause educational materials as a member of the Hormone Foundation’s Women’s Health Task Force. A Founding Member and Past President of the North American Menopause Society (NAMS) and two-term member of the NAMS Board of Trustees, Dr. Stuenkel served as the Scientific Chair for the 23rd NAMS Annual Meeting in 2012 and was awarded the Leon Speroff Outstanding Educator Award. She serves on the Editorial Board of Menopause and the Advisory Panels for the NAMS Hormone Therapy Position Statements from 2007 through the 2017 update. She was instrumental in development of the first NAMS/APGO (Association of Professors of Gynecology and Obstetrics) menopause curriculum released in 2012, Contemporary Clinical Management of Menopause. She recently participated in several Medscape productions and as a WebMD Menopause Expert. She was a contributing author of the American College of Obstetricians and Gynecologists 2004 Statement on Hormone Therapy and served on the Editorial Board of their consumer publication, Pause. Dr. Stuenkel served as a clinical investigator in pivotal clinical trials including the Heart and Estrogen/Progestin Replacement Study (HERS), Raloxifene Use for the Heart (RUTH), and Long-Term Interventions on Fractures with Tibolone (LIFT). She has authored or coauthored editorials, reviews, and book chapters and appeared in local, national, and international media.
